Despite the improvement in systemic inflammation (CRP, blood leukocytes, serum IgA), we observed an increase in pro-inflammatory fecal LPS and flagellin abundance after RYGB surgery (Figure 3a–b, Table S7), without obvious differences between ND and T2D (Table S8). The gene discussed is CD79A; the disease is type 2 diabetes mellitus.